Universe Pharmaceuticals (UPC) Investment Income: 2021-2024
- Universe Pharmaceuticals' Investment Income rose 85.35% to -$4.2 billion in Q1 2024 from the same period last year, while for Mar 2024 it was -$111.7 billion, marking a year-over-year change of. This contributed to the annual value of $31,881 for FY2023, which is N/A change from last year.
- According to the latest figures from Q1 2024, Universe Pharmaceuticals' Investment Income is -$4.2 billion, which was up 20.05% from -$5.2 billion recorded in Q3 2023.
- Universe Pharmaceuticals' 5-year Investment Income high stood at -$4.2 billion for Q1 2024, and its period low was -$74.1 billion during Q3 2022.
- For the 3-year period, Universe Pharmaceuticals' Investment Income averaged around -$27.9 billion, with its median value being -$16.8 billion (2023).
- Its Investment Income has fluctuated over the past 5 years, first crashed by 71.90% in 2022, then surged by 92.99% in 2023.
- Over the past 4 years, Universe Pharmaceuticals' Investment Income (Quarterly) stood at -$43.1 billion in 2021, then slumped by 71.90% to -$74.1 billion in 2022, then spiked by 92.99% to -$5.2 billion in 2023, then surged by 85.35% to -$4.2 billion in 2024.
- Its Investment Income stands at -$4.2 billion for Q1 2024, versus -$5.2 billion for Q3 2023 and -$28.3 billion for Q1 2023.
